Thermo Fisher Scientific Income Tax at U.S. Statutory Rate increased by 7.1% to $364.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $340.00M to $364.00M.
Used as a benchmark to evaluate how much the company's actual tax rate deviates from the statutory norm.
The theoretical income tax expense calculated by applying the U.S. federal statutory tax rate to the company's income be...
Standard disclosure in the tax rate reconciliation table for all U.S. public companies.
cat_income_tax_at_statutory_rate| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $430.00M | $456.00M | $533.00M | $403.00M | $336.00M | $286.00M | $301.00M | $370.00M | $334.00M | $370.00M | $366.00M | $340.00M | $364.00M |
| QoQ Change | — | +6.0% | +16.9% | -24.4% | -16.6% | -14.9% | +5.2% | +22.9% | -9.7% | +10.8% | -1.1% | -7.1% | +7.1% |
| YoY Change | — | — | — | -6.3% | -26.3% | -46.3% | -25.3% | +10.1% | +16.8% | +22.9% | -1.1% | +1.8% | +7.1% |